首页>
外国专利>
TREATMENT OF REFRACTORY OF RELAPSED HEMATOLOGICAL CANCER WITH DURVALUMAB
TREATMENT OF REFRACTORY OF RELAPSED HEMATOLOGICAL CANCER WITH DURVALUMAB
展开▼
机译:用杜伐单抗治疗难治性或复发性造血癌
展开▼
页面导航
摘要
著录项
相似文献
摘要
Provided herein is a method of treating, preventing, or managing a hematological cancer in a subject having failed a CD19-directed CAR-T cell therapy, comprising administering to the subject in need thereof a therapeutically or prophylactically effective amount of durvalumab.
展开▼